We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600845:SSEShanghai Baosight Software Co., Ltd. Class A Analysis

Data as of 2026-06-02 - not real-time

CN¥20.70

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Shanghai Baosight Software is trading at CNY 20.7, barely above the computed support of CNY 20.15 and well below the resistance of CNY 25, while the 20‑day SMA (22.74) and 50‑day SMA (22.60) sit higher, indicating limited upside in the near term. Technical indicators are mixed: the RSI of 37 suggests the stock is approaching oversold conditions, but the MACD line (‑0.68) is below its signal (‑0.34) and the histogram is negative, signaling bearish momentum. Volatility is high at 39% over the past 30 days, and the beta is essentially flat (‑0.02), reflecting a stock that moves independently of the market.
On the fundamentals side, the company posts a modest revenue growth of 4.2% and healthy margins (gross 30.6%, operating 16.4%, profit 11.2%), yet the valuation is stretched with a trailing PE of 48.1 versus an industry average of 42.9 and a price‑to‑book of 5.2. The DCF‑derived fair value of only CNY 4.09 underscores the degree of overvaluation. Dividend yield is modest at 1.12% but the payout ratio exceeds 138%, raising concerns about sustainability. Overall, the stock faces medium‑level sector and regulatory risks in China’s technology space, while liquidity appears adequate despite a decreasing volume trend.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and negative histogram
  • Price near support with limited upside to resistance
  • Extreme overvaluation relative to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Modest revenue growth and solid operating margins
  • High PE and unsustainable dividend payout
  • Neutral trend direction with high volatility

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Stable cash flow generation and decent ROE
  • Persistent regulatory headwinds in Chinese tech sector
  • Valuation gap suggests limited long‑term upside

Key Metrics & Analysis

Financial Health

Revenue Growth4.20%
Profit Margin11.21%
P/E Ratio48.1
ROE10.18%
ROA3.48%
Debt/Equity14.16
P/B Ratio5.2
Op. Cash FlowCN¥2.2B
Free Cash FlowCN¥576.3M
Industry P/E42.9

Technical Analysis

TrendNeutral
RSI37.4
SupportCN¥20.15
ResistanceCN¥25.00
MA 20CN¥22.74
MA 50CN¥22.60
MA 200CN¥22.93
MACDBearish
VolumeDecreasing
Fear & Greed Index92.77

Valuation

Fair ValueCN¥4.09
GradeOvervalued
TypeBlend
Dividend Yield1.12%

Risk Assessment

Beta-0.02
Volatility39.22%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.